TCL Archive Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines. March 31, 2000
TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive In Brief: Oncology Nurse Rumored For NCAB; Rosenberg To Give Karofsky Lecture; Fundraiser’s $$ Short December 14, 1990